Literature DB >> 7697214

Morphological changes and proliferative activity of alveolar epithelium in mouse lungs treated with urethan.

Y Monobe1, T Manabe.   

Abstract

We have observed sequential cellular changes in type II pneumocytes in mouse lungs following oral administration of 0.1% urethan solution. Histologically, scatterings of swollen alveolar cells were first noticed 25 days after administration. These cells continued to swell further, after which they aggregated more compactly to form a papillary structure by day 75. After day 100, distinct tumour nodules were found with atypical large cells in some areas. Necrotic foci appeared in large tumours of more than 4 mm diameter. At day 250, nucleoli became distinct and large bizarre and multinucleated cells were intermingled with some mitotic figures. These morphologies correspond to conventional descriptions; that is, hyperplasia (day 25-75), benign neoplastic changes (day 75-100) and malignant neoplastic changes (day 100-250). The proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (AgNOR) scores in these lesions increased with time, and proliferative activities during tumour progression seemed continuous. However, proliferative activity of the cells on specific days did not differ statistically from the values on neighboring days. We speculate that the hyperplasia-like lesions seen in our mice are neoplastic in nature from their outset.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7697214     DOI: 10.1007/bf00199346

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  11 in total

1.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

2.  Alkylation of protein and DNA in mice treated with urethane.

Authors:  K Svensson
Journal:  Carcinogenesis       Date:  1988-12       Impact factor: 4.944

3.  Multiple molecular alterations in mouse lung tumors.

Authors:  F C Re; G Manenti; M G Borrello; M P Colombo; J H Fisher; M A Pierotti; G Della Porta; T A Dragani
Journal:  Mol Carcinog       Date:  1992       Impact factor: 4.784

4.  Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis.

Authors:  R L Garcia; M D Coltrera; A M Gown
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.

Authors:  P A Dervan; L G Gilmartin; B M Loftus; D N Carney
Journal:  Am J Clin Pathol       Date:  1989-10       Impact factor: 2.493

6.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

7.  Incidence of atypical bronchioloalveolar cell hyperplasia of the lung: relation to histological subtypes of lung cancer.

Authors:  S Y Weng; E Tsuchiya; T Kasuga; H Sugano
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

8.  Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.

Authors:  J Crocker; J C Macartney; P J Smith
Journal:  J Pathol       Date:  1988-02       Impact factor: 7.996

9.  Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

Authors:  P A Hall; D A Levison; A L Woods; C C Yu; D B Kellock; J A Watkins; D M Barnes; C E Gillett; R Camplejohn; R Dover
Journal:  J Pathol       Date:  1990-12       Impact factor: 7.996

10.  Nucleolar organiser regions in small cell carcinoma of the bronchus.

Authors:  J Crocker; J Ayres; J McGovern
Journal:  Thorax       Date:  1987-12       Impact factor: 9.139

View more
  1 in total

1.  Lung tumor development in the presence of sphingosine 1-phosphate agonist FTY720.

Authors:  Natália R Salinas; Camila T Lopes; Patrícia V Palma; Celina T Oshima; Valquiria Bueno
Journal:  Pathol Oncol Res       Date:  2009-02-12       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.